期刊文献+

小鼠CD4+ CD25+免疫调节性T细胞体外扩增及功能检测的研究 被引量:4

Amplification of mice CD4+ CD25+ regulatory T cells in vitro and it's function detection
原文传递
导出
摘要 目的 探讨小鼠CD4+ CD25+调节性T细胞(Tregs)的体外扩增方法及扩增后Tregs的免疫功能.方法 利用免疫磁珠法分离小鼠Tregs;采用anti-CD3mAb+rIL-2和Allo-APC+rIL-2两种方法进行体外扩增,通过TRANSWELL培养系统、细胞因子表达及CFSE染色标记等方法检测Tregs免疫抑制作用的机制.结果 体外分离的Tregs纯度为89.5%;活细胞率约为98%.Tregs扩增的倍数在两组各时间点差异无统计学意义.扩增后CD4+ CD25+T细胞、CD4+T细胞和CD4+ CD25-T细胞的每分钟计数(CPM)分别为1 470、12 700和14 300.混合淋巴细胞反应(MLR)中当CD4+:CD25+T细胞的比例为1∶1时,抑制率为79%,比例为8∶1时,抑制率为33%.CFSE标记后,进入分裂周期的CD4+T细胞的百分比在未加入CD4+ CD25+T细胞组为83.7%,加入CD4+ CD25+T细胞组为31.7%,差异具有统计学意义(P=0.0006).CD4+ CD25+T细胞对CD4+T细胞的增殖抑制率在Transwell和Non-Transwell的培养系统中分别为<5%和95%.Transwell培养组中IL-2含量高于Non-Transwell组,差异具有统计学意义[Transwell培养组为(158.33±2.08)pg/mL,Non-Transwell组为(23.00±2.00) pg/mL,P <0.0001].结论 采用免疫磁珠法分离小鼠Tregs可行,Tregs可有效扩增;Tregs的作用机制为抑制CD4+T细胞的增殖及抑制CD4+T细胞分泌IL-2;其抑制作用需要细胞-细胞间接触;体外扩增后的Tregs仍具有免疫特性,其体外免疫抑制作用增强. Objective To detect the immune function of CD4 + CD25 +T cells (Tregs),amplified in vitro.Methods We used the micro-magnetic beads to isolate Tregs.Two means were adopted to amplify Tregs (anti-CD3mAb group and allo-APC group).The function of Tregs was detected with the Transwell system,cytokine detection and CFSE marker.Results The purity of Tregs is 89.5%.The amplification times were not significantly deferent between the two groups.The counts per minute(CPM) of CD4 + CD25 +T cell,CD4 + T cell and CD4 + CD25T cell is 1 470,12 700 and 14 300 respectived.In mixed lymphocyte reaction (MLR),when the ratio of CD4/CD25+ T cell is 1∶ 1 and 8∶1,suppression ratio is 79% and 33%.We labeled CD4+T cells with CFSE,the percent is 83.7 % without Tregs,and 31.7 % with Tregs (P =0.0006).The proliferation inhibition ratio inducedby is 5% in Transwell system and 95% in Non-Transwell system.The concentration of IL-2 in Transwell system is significantly higher than that in Non-Transwell(158.33 ± 2.08) pg/mL vs (23.00 ± 2.00) pg/mL,P < 0.0001).Conclusion The method of micro-magnetic beads can be used to isolate Tregs.Tregs can be amplified effectively and inhibit CD4 +T cells proliferation.Tregs amplified in vitro still have immune with function with enhanced immune-suppressive effect.
出处 《国际免疫学杂志》 CAS 2014年第6期526-530,共5页 International Journal of Immunology
基金 吉林省科技厅资助项目(201215201)
关键词 CD4+ CD25+免疫调节T细胞 体外扩增 CD4+ CD25+ regulatory T cells In vitro amplification
  • 相关文献

参考文献13

  • 1Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25).Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J].J Immunol,1995,155(3):1151-1164.
  • 2巫翠萍,覃西,巫翠云,何金龙,周海燕,温晓梅.急性淋巴细胞白血病患者CD4+CD25+调节性T细胞水平变化[J].国际免疫学杂志,2011,34(6):390-392. 被引量:4
  • 3牟冠男,徐雯.调节性T细胞在急性髓细胞白血病中的作用[J].国际免疫学杂志,2013,36(2):106-111. 被引量:6
  • 4张卫平.中医药的疾病干预与调节性T细胞关联性的研究进展[J].中国免疫学杂志,2011,27(11):1045-1049. 被引量:6
  • 5Schuler PJ,B(o)rger V,B(o)lke E,et al.Dendritic cell generation and CD4 + CD25highFoxp3 + regulatory T cells in human head and neck carcinoma during radio-chemotherpy[J].Eur J Med Res,2011,16(2):57-62.
  • 6Kuniyasu Y,Takahashi T,Itoh M,et al.Naturally anergic and suppressive CD25 + CD4 + T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation[J].Int Immunol,2000,12(8):1145-1155.
  • 7Thornton AM,Shevach EM.Suppressor effector function of CD4 +CD25 + immunoregulatory T cells is antigen nonspeciflc[J].J Immunol,2000,164(1):183-190.
  • 8Cederbom L,Hall H,Ivars F.CD4 + CD25 + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells[J].Eur J Immunol,2000,30(6):1538-1543.
  • 9Read S,Malmstr(o)m V,Powrie F.Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25 + CD4 + regulatory cells that control intestinal inflammation[J].J Exp Med,2000,192 (2):295-302.
  • 10Graca L,Cobbold SP,Waldmann H.Identification of regulatory T cells in tolerated allografts[J].J Exp Med,2002,195 (12):1641-1646.

二级参考文献69

共引文献13

同被引文献68

  • 1尤平洪,卢一平.一种新型的IL-2R受体阻滞剂——抗CD25单克隆抗体[J].华西医学,2007,22(3):659-660. 被引量:7
  • 2Choi SW, Reddy P. Current and emerging strategies for the preven- tion ofgraft-versus-host disease [ J ]. Nat Rev Clin Oncol, 2014,11 (9) :536-547.
  • 3Li Z, Li D, Tsun A, et al. FOXP3 + regulatory T ceils and their functional regulation [ J ]. Cell Mol Immunol. 2015 Feb 16. doi: 10. 1038/cmi. 2015,10.
  • 4Perez L,Anasetti C,Pidala J. Have we improved in preventing and treating acute graft-versus-host disease [ J ]. Curt Opin Hematol, 2011,18(6) :408-413.
  • 5Sellar RS, Peggs KS. Recent progress in managing graft-versus-host disease and viral infections following allogeneic stem cell transplan- tation[J]. Future Oncol,2012,8(12) :1549-1565.
  • 6Chen YB,Cutler CS. Biomarkers for acute GVHD: can we predict the unpredictable[J]? Bone Marrow Transplant,2013,48(6) :755-760.
  • 7Sawamukai N, Satake A, Schmidt AM, et, al. Ceil-autonomous role of TGF and IL-2 receptors in CIM + and CD8+ inducible regula- tory T-cell generation during GVHD [ J ]. Blood, 2012,119 ( 23 ) : 5575-5583.
  • 8Levine JE,Logan BR,Wu J, et al. Acute graft-versus-host disease biomarkers measured during therapy can predict treatment out- comes: a Blood and Marrow Transplant Clinical Trials Network study[J]. Blood,2012,119(16) :3854-3860.
  • 9Ito S, Boilard CM, Carlsten M, ct, al. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T ceils and nat- ural killer cells in healthy volunteers[ J]. Mol Ther,2014,22(7 ) : 1388-1395.
  • 10Kennedy-Nasser AA, Ku S, Castiilo-Caro P, et al. Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem ceil transplantation mediates expansion of regulatory T cells without di- minishing antiviral and antileukemic activity [ J ]. Clin Cancer Res, 2014,20(8) :2215-2225.

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部